Ian Levine
Ian Levine is currently Founder in Residence at Foundations and Co-Founder and CEO at ModernVivo, a startup developing AI-enabled software for life sciences companies. He has expertise in drug discovery and preclinical study design.
ModernVivo uses AI to analyze millions of animal studies, cutting literature review from weeks to minutes
ModernVivo, a Seattle startup, uses AI to scan millions of published animal studies and related data to help researchers design preclinical drug experiments faster, reducing literature review time from weeks to minutes and aiming to improve experiment quality while using fewer animals.
ModernVivo launches ModernVivo Marketplace on Sept. 15, 2026 to connect preclinical teams with pre-vetted CROs
ModernVivo announced on Sept. 15, 2026 the launch of ModernVivo Marketplace, a service to help preclinical R&D teams find pre-vetted CROs faster for in vivo study design and execution.
Organizations
See all 5-
Foundations Founder in Residence 2025–present · current
-
ModernVivo Co-Founder and CEO 2021–present · current
-
miLEAD Consulting Consultant 2021–2022 · past
Education
-
University of Michigan Master of Science - MS, Pharmacology · 2021–2023
-
Virginia Tech Experimental Neuroscience · 2016–2020